Elke de Boer

Elke de Boer

Auto-generated profile, based on publicly available information

Elke de Boer

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Nature
Verified
Journal Article
Closed access
PDF file
JKJoanna Kaplanis
Joanna Kaplanis
KSKaitlin E. Samocha
Kaitlin E. Samocha
LWLaurens Wiel
Laurens Wiel
ZZZhancheng Zhang
Zhancheng Zhang
KAKevin J. Arvai
Kevin J. Arvai
KRKyle Retterer
Kyle Retterer

7 August 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ADAlexander J. M. Dingemans
Alexander J. M. Dingemans
MHMax Hinne
Max Hinne
KTKim M. G. Truijen
Kim M. G. Truijen
LGLia Goltstein
Lia Goltstein
JRJeroen van Reeuwijk
Jeroen van Reeuwijk
BVBert B. A. de Vries
Bert B. A. de Vries

29 June 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ATAlan P. Tenney
Alan P. Tenney
SGSilvio Alessandro Di Gioia
Silvio Alessandro Di Gioia
BWBryn D. Webb
Bryn D. Webb
WCWai-Man Chan
Wai-Man Chan
EBElke de Boer
Elke de Boer
EEElizabeth C Engle
Elizabeth C Engle
Hereditary congenital facial paresis type 1 (HCFP1) is an autosomal dominant disorder of absent or limited facial movement that maps to chromosome 3q21-q22 and is hypothesized to result from facial branchial motor neuron (FBMN) maldevelopment. In the present study, we report that HCFP1 results from heterozygous duplications within a neuron-specific GATA2 regulatory region that includes two enhancers and one silencer, and from noncoding single-nucleotide variants (SNVs) within the silencer. Some SNVs impair binding of NR2F1 to the silencer in vitro and in vivo and attenuate in vivo enhancer reporter expression in FBMNs. Gata2 and its effector Gata3 are essential for inner-ear efferent neuron (IEE) but not FBMN development. A humanized HCFP1 mouse model extends Gata2 expression, favors the formation of IEEs over FBMNs and is rescued by conditional loss of Gata3. These findings highlight the importance of temporal gene regulation in development and of noncoding variation in rare mendelian disease.

14 July 2022 in Genetics in Medicine
Verified
Journal Article
Open access
EBElke de Boer
Elke de Boer
COCharlotte W. Ockeloen
Charlotte W. Ockeloen
RKRosalie A. Kampen
Rosalie A. Kampen
JHJuliet E. Hampstead
Juliet E. Hampstead
ADAlexander J.M. Dingemans
Alexander J.M. Dingemans
TKTjitske Kleefstra
Tjitske Kleefstra
Although haploinsufficiency of ANKRD11 is among the most common genetic causes of neurodevelopmental disorders, the role of rare ANKRD11 missense variation remains unclear. We characterized clinical, molecular, and functional spectra of ANKRD11 missense variants. We collected clinical information of individuals with ANKRD11 missense variants and evaluated phenotypic fit to KBG syndrome. We assessed pathogenicity of variants through in silico analyses and cell-based experiments. We identified 20 unique, mostly de novo, ANKRD11 missense variants in 29 individuals, presenting with syndromic neurodevelopmental disorders similar to KBG syndrome caused by ANKRD11 protein truncating variants or 16q24.3 microdeletions. Missense variants significantly clustered in repression domain 2 at the ANKRD11 C-terminus. Of the 10 functionally studied missense variants, 6 reduced ANKRD11 stability. One variant caused decreased proteasome degradation and loss of ANKRD11 transcriptional activity. Our study indicates that pathogenic heterozygous ANKRD11 missense variants cause the clinically recognizable KBG syndrome. Disrupted transrepression capacity and reduced protein stability each independently lead to ANKRD11 loss-of-function, consistent with haploinsufficiency. This highlights the diagnostic relevance of ANKRD11 missense variants, but also poses diagnostic challenges because the KBG-associated phenotype may be mild and inherited pathogenic ANKRD11 (missense) variants are increasingly observed, warranting stringent variant classification and careful phenotyping.

16 October 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
JKJoanna Kaplanis
Joanna Kaplanis
KSKaitlin E Samocha
Kaitlin E Samocha
LWLaurens Wiel
Laurens Wiel
ZZZhancheng Zhang
Zhancheng Zhang
KAKevin J. Arvai
Kevin J. Arvai
KRKyle Retterer
Kyle Retterer
Summary: De novo mutations (DNMs) in protein-coding genes are a well-established cause of developmental disorders (DD). However, known DD-associated genes only account for a minority of the observed excess of such DNMs. To identify novel DD-associated genes, we integrated healthcare and research exome sequences on 31,058 DD parent-offspring trios, and developed a simulation-based statistical test to identify gene-specific enrichments of DNMs. We identified 285 significantly DD-associated genes, including 28 not previously robustly associated with DDs. Despite detecting more DD-associated genes than in any previous study, much of the excess of DNMs of protein-coding genes remains unaccounted for. Modelling suggests that over 1,000 novel DD-associated genes await discovery, many of which are likely to be less penetrant than the currently known genes. Research access to clinical diagnostic datasets will be critical for completing the map of dominant DDs.

27 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
WSWouter Steyaert
Wouter Steyaert
LHLonneke Haer-Wigman
Lonneke Haer-Wigman
RPRolph Pfundt
Rolph Pfundt
DHDebby Hellebrekers
Debby Hellebrekers
MSMarloes Steehouwer
Marloes Steehouwer
CGChristian Gilissen
Christian Gilissen
The short lengths of short-read sequencing reads challenge the analysis of paralogous genomic regions in exome and genome sequencing data. Most genetic variants within these homologous regions therefore remain unidentified in standard analyses. Here, we present a method (Chameleolyser) that accurately identifies single nucleotide variants and small insertions/deletions (SNVs/Indels), copy number variants and ectopic gene conversion events in duplicated genomic regions using whole-exome sequencing data. Application to a cohort of 41,755 exome samples yields 20,432 rare homozygous deletions and 2,529,791 rare SNVs/Indels, of which we show that 338,084 are due to gene conversion events. None of the SNVs/Indels are detectable using regular analysis techniques. Validation by high-fidelity long-read sequencing in 20 samples confirms >88% of called variants. Focusing on variation in known disease genes leads to a direct molecular diagnosis in 25 previously undiagnosed patients. Our method can readily be applied to existing exome data.